Analyst Insight
Here’s the Reason why Reata Pharmaceuticals, Inc. (RETA) Stock is Tumbling
Reata Pharmaceuticals, Inc., (RETA) develops innovative therapeutics for patients with life-threatening renal and cardiovascular diseases, by targeting molecular pathways involved in the regulation of cellular
